Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Global Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
In accordance with US securities regulations, Novartis files reports with the Securities and Exchange Commission. View all of the Novartis filings through EDGAR, the Electronic Data Gathering, Analysis and Retrieval system, on the SEC website.
© 2013 Novartis AG Terms of usePrivacy policy Sitemap
